Rapamycin
Showing 26 - 50 of 820
Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Keloid Trial in San Antonio (Rapamycin 8% Ointment, Placebo)
Completed
- Keloid
- Rapamycin 8% Ointment
- Placebo
-
San Antonio, TexasAudie L Murphy Memorial Veterans Hospital
Sep 1, 2021
Coronary Artery Disease, Coronary Stenosis Trial (Rapamycin target eluting stent)
Not yet recruiting
- Coronary Artery Disease
- Coronary Stenosis
- Rapamycin target eluting stent
- (no location specified)
Oct 13, 2021
Pachyonychia Congenita Trial in United Kingdom, United States (QTORIN 3.9% rapamycin anhydrous gel, Vehicle)
Recruiting
- Pachyonychia Congenita
- QTORIN 3.9% rapamycin anhydrous gel
- Vehicle
-
Palo Alto, California
- +7 more
Feb 25, 2022
Diabetes, Type 1 Trial in Milan (Human pancreatic islet, ATG, Pegylated G-CSF)
Active, not recruiting
- Diabetes Mellitus, Type 1
- Human pancreatic islet
- +3 more
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Dec 1, 2022
Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )
Completed
- Facial Angiofibroma
- Tuberous Sclerosis
- rapamycin
- placebo
-
Phoenix, Arizona
- +16 more
Jul 26, 2022
Pulmonary Hypertension Trial in United States (ABI-009, nab-rapamycin, albumin-bound rapamycin)
Active, not recruiting
- Pulmonary Hypertension
- ABI-009, nab-rapamycin, albumin-bound rapamycin
-
Tucson, Arizona
- +5 more
Aug 22, 2022
Vascular Anomalies Trial in Guangzhou (Treatment with oral rapmycin)
Recruiting
- Vascular Anomalies
- Treatment with oral rapmycin
-
Guangzhou, Guangdong, ChinaZhujiang Hospital
Nov 9, 2021
Cancer of Breast Trial in San Antonio (Rapamycin)
Active, not recruiting
- Cancer of Breast
- Rapamycin
-
San Antonio, TexasUniversity of Texas Health Science Center San Antonio
Mar 6, 2022
Anemia, Sickle Cell Trial in New York (Siplizumab, Exchange Transfusion, Total Body Irradiation)
Recruiting
- Anemia, Sickle Cell
- Siplizumab
- +7 more
-
New York, New YorkColumbia University Irving Medical Center
Oct 9, 2023
Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)
Recruiting
- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2022
Aging, Epigenetics, Inflammatory Mediators Trial in San Antonio (Rapamycin Topical Ointment, Placebo)
Active, not recruiting
- Aging
- +2 more
- Rapamycin Topical Ointment
- Placebo
-
San Antonio, TexasUTHSCSA
May 4, 2022
Aging Trial in San Antonio (rapamycin)
Recruiting
- Aging
- rapamycin
-
San Antonio, Texas
- +1 more
May 17, 2022
Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)
Recruiting
- Castleman Disease
- Castleman's Disease, Multicentric
-
Little Rock, Arkansas
- +3 more
Jan 6, 2023
Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)
Recruiting
- Kaposiform Hemangioendothelioma
- Kasabach-Merritt Syndrome
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Oct 21, 2022
Dermal Atrophy Trial in Philadelphia (Rapamycin)
Completed
- Dermal Atrophy
- Rapamycin
-
Philadelphia, PennsylvaniaDrexel Dermatology
Sep 21, 2021
Sirolimus in Graves' Orbitopathy
Completed
- Graves Ophthalmopathy
-
Pisa, PI, ItalyEndocrinologia II
Apr 19, 2022
Vascular Anomaly Trial in Chengdu (Sirolimus)
Completed
- Vascular Anomaly
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Mar 12, 2022
Hemangioendothelioma Trial in Chengdu (Sirolimus)
Recruiting
- Hemangioendothelioma
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 1, 2022
Bladder Cancer Trial in San Antonio (Sirolimus)
Completed
- Bladder Cancer
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Mar 17, 2021
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
DES In-stent Stenosis Trial in Malaysia (Paclitaxel coated balloon (SeQuent Please), Sirolimus coated balloon)
Completed
- DES In-stent Stenosis
- Paclitaxel coated balloon (SeQuent Please)
- Sirolimus coated balloon
-
Kota Kinabalu, Malaysia
- +4 more
Aug 24, 2021
Solid Organ Transplant Recipients, Skin Cancer Trial in Australia (Sirolimus Topical Cream, Placebo)
Not yet recruiting
- Solid Organ Transplant Recipients
- Skin Cancer
- Sirolimus Topical Cream
- Placebo
-
Camperdown, New South Wales, Australia
- +5 more
May 8, 2023
Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)
Recruiting
- Kaposiform Hemangioendothelioma
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Apr 6, 2022
Lymphangioleiomyomatosis Trial in Spain (Loratadine, Placebo 10mg/day added to rapamycin for 12 months)
Recruiting
- Lymphangioleiomyomatosis
- Loratadine
- Placebo 10mg/day added to rapamycin for 12 months
-
Hospitalet de Llobregat, Barcelona, Spain
- +5 more
Jan 12, 2022